Bioventus

Company Snapshot

Founded: 2012
Entity Type: Public
Employees: 930
Region: U.S.
Revenue: $568.1 Millions
Revenue Year: 2025
Segment: Pain Treatments
Headquarter: North Carolina, U.S.
Key Geographics: U.S.
Corporate Address: 4721 Emperor Boulevard, Suite 100 Durham, North Carolina 27703 U.S. Tel. +1 -919-474-6700 www.bioventus.com

Company Overview

Bioventus is a medical product company focused on regenerative medicine. It focuses on developing and marketing minimally invasive, cost-effective, and therapeutically unique products that stimulate and improve the body's natural healing process. Its non-invasive medical devices and biologic products play a crucial role in supporting the body's natural healing processes, enabling the treatment or alleviation of pain associated with orthopedic disorders. Bioventus operates in three business segments: pain treatments, surgical solutions, and restorative therapies. It operates in 37 countries. It directly distributes products in the U.S., Canada, the U.K., Germany, and the Netherlands. In other markets, it distributes its products through independent distributors.

Financial Highlights (FY 2025)

Net Revenue: ***
Total Current Liabilities: ***
Total Current Assets: ***
R&D expenses: ***
Operating Income: ***

This information is available for BCC Research members only.

Bioventus In Reports

Biologic Therapies for Wound Care: Technologies and Global Markets

According to BCC Research detailed report on Biologic Therapies for Wound Care Markets includes global revenue ($ billion) for the base year (2024), estimated data for 2025, and forecast data for 2026 to 2030.

Hyaluronic Acid in Healthcare: Global Markets

Our Research report provides an overview of the Hyaluronic Acid in Healthcare Markets landscape, develop business/growth strategies, and analyze their market position. BCC Research estimates market size for 2024 (the...

Neuroprosthetics: Technologies and Global Markets

BCC Research's report on neuroprosthetics technologies provides a comprehensive overview of the global market for neuroprosthetics, including current and projected market forecasts for the period 2023-2028.

Company's Business Segments

  • Pain Treatments : The segment is comprised of Non-surgical Pain Injection Therapies, Peripheral Nerve Stimulation products.
  • Restorative Therapies : The segment is comprised of a Bone Stimulation System, other devices designed to help patients regain leg or hand function.
  • Surgical Solutions : The segment is comprised of Bone Graft Substitutes, a portfolio of Ultrasonic Products.

Applications/End User Industries

  • Healthcare
  • Clinics
  • Pharmacies
  • Surgeons
  • Physicians
  • Cardiologists
  • Physiatrists
  • Rehabilitation Physicians
  • Restorative Therapies
  • Orthopaedic
AI Sentiment